XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Jul. 27, 2024
Jul. 29, 2023
Cash flows from operating activities    
Net income $ 26,804 $ 27,926
Adjustments to reconcile net income to cash provided by operating activities    
(Gain)/loss on disposal and impairment of assets (117) 113
(Gain)/loss on sale of investments (80) 307
Provision for doubtful accounts 91 (405)
Depreciation and amortization 12,147 10,211
Amortization of right-of-use lease assets 22,722 17,265
Lease impairment/(settlement) 0 (1,175)
Equity-based compensation expense 3,175 2,526
Change in deferred taxes 1,999 602
Change in receivables 17,783 14,769
Change in inventories (6,912) 9,271
Change in other assets (6,668) (2,820)
Change in payables 952 (8,565)
Change in lease liabilities (23,306) (17,882)
Change in other liabilities 3,728 (26,230)
Net cash provided by operating activities 52,318 25,913
Cash flows from investing activities    
Proceeds from disposals of assets 158 4,031
Capital expenditures (15,620) (13,457)
Purchases of investments (2,813) (11,407)
Proceeds from sales of investments 7,879 12,404
Acquisitions (6,797) (4,250)
Net cash used for investing activities (17,193) (12,679)
Cash flows from financing activities    
Payments on finance lease liabilities (145) (67)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes 7,874 (1,978)
Repurchases of common stock (33,673) (10,007)
Dividends paid to shareholders (8,371) (7,852)
Net cash used for financing activities (34,315) (19,904)
Effect of exchange rate changes on cash and equivalents 362 242
Change in cash, cash equivalents and restricted cash 1,172 (6,428)
Cash, cash equivalents and restricted cash at beginning of period 341,098 346,678
Cash, cash equivalents and restricted cash at end of period 342,270 340,250
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 2,583 $ 7,188